March 7, 2019

Litera Microsystems has announced Epizyme, a biopharmaceutical company headquartered in Cambridge, MA, has recently chosen to implement DocXtools to enhance their medical writing workflow. The company will roll out the solution to its writers, accelerating the creation, review, comparison, and formatting of their documents.

Matt Miller, Litera Microsystems Director of Life Sciences Products, said, “We’re delighted that Epizyme has chosen to leverage our solutions to reduce time spent drafting, reviewing, and finalizing their documents. We’re looking forward to working with them as they continue to invest in research and aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action.”

About Litera Microsystems

Litera Microsystems is the leading provider of software for drafting, proofreading, comparing, repairing, cleaning and securing documents in the legal and life sciences industries worldwide. Our core products empower users to generate, review, and distribute high-quality content quickly and securely, from any device. Today, Litera Microsystems supports thousands of document-intensive organizations across the globe, helping them satisfy the complex demands of clients and regulators.